Thorac Cardiovasc Surg 2019; 67(06): 484-487
DOI: 10.1055/s-0038-1667322
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Low-Volume Cardioplegia and Myocardial Protection in Coronary Artery Bypass Graft Surgery

Authors

  • Samuel Tschopp

    1   Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland
  • Friedrich Eckstein

    1   Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland
  • Peter Matt

    2   Department of Cardiac Surgery, Herzzentrum Luzern, Luzern, Switzerland
Further Information

Publication History

23 April 2018

26 June 2018

Publication Date:
02 August 2018 (online)

Abstract

We studied myocardial protection during coronary artery bypass graft surgery using low-volume cardioplegia (Cardioplexol) and minimal extracorporeal circulation (MECC) for different types of coronary artery diseases. In total, 426 consecutive patients were included and divided into four groups: those with left main stem stenosis (n = 45), those with three-vessel disease (n = 200), those with both (n = 141), and those with neither (n = 40). The peak postoperative myocardial markers and 30-day mortality were analyzed. Both myocardial markers and 30-day mortality were significantly elevated in patients with isolated main stem stenosis. We conclude that the use of low-volume cardioplegia and MECC is safe. However, patients with underlying isolated left main stem stenosis might be less protected.